Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice

Molecular Pharmacology

Volumn 79, Issue 3, 2011, Pages 420-431

  Feng, Wei ^a   Barrientos, Genaro C ^a   Cherednichenko, Gennady ^a   Yang, Tianzhong ^b   Padilla, Isela T ^a   Truong, Kim ^a   Allen, Paul D ^b   Lopez, José R ^b   Pessah, Isaac N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; FK 506 BINDING PROTEIN; GLUTATHIONE; HALOTHANE; RYANODINE RECEPTOR 1;

ANIMAL CELL; ARTICLE; CYTOPLASM; DEPHOSPHORYLATION; DRUG SENSITIVITY; ELECTRIC FIELD; GENOTYPE; HETEROZYGOSITY; IMMUNOBLOTTING; IN VIVO STUDY; MALIGNANT HYPERTHERMIA; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SARCOPLASMIC RETICULUM; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CALCIUM; HETEROZYGOTE; MALIGNANT HYPERTHERMIA; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION; PROTEIN PHOSPHATASE 1; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 79951981187     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.067959     Document Type: Article

References (40)

1. Airey JA, Beck CF, Murakami K, Tanksley SJ, Deerinck TJ, Ellisman MH, and Sutko JL (1990) Identification and localization of two triad junctional foot protein isoforms in mature avian fast twitch skeletal muscle. J Biol Chem 265:14187-14194.
2. Balog EM, Fruen BR, Shomer NH, and Louis CF (2001) Divergent effects of the malignant hyperthermia-susceptible Arg(615)→Cys mutation on the Ca(2+) and Mg(2+) dependence of the RyR1. Biophys J 81:2050-2058. (Pubitemid 32917155)
3. Bannister RA, Estève E, Eltit JM, Pessah IN, Allen PD, López JR, and Beam KG (2010) A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels. J Gen Physiol 135:629-640.
4. 2+ sparks and T tubule reorganization in dedifferentiating adult mouse skeletal muscle fibers. Am J Physiol Cell Physiol 292:C1156-C1166.
5. Buck ED, Nguyen HT, Pessah IN, and Allen PD (1997) Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function. J Biol Chem 272:7360-7367. (Pubitemid 27166446)
6. Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, Pessah IN, Zhang P, Bhattacharjee MB, Dirksen RT, et al. (2006) Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J 20:329-330. (Pubitemid 46671160)
7. 2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci USA 101:15793-15798.
8. Cherednichenko G, Ward CW, Feng W, Cabrales E, Michaelson L, Samso M, López JR, Allen PD, and Pessah IN (2008) Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol 73:1203-1212. (Pubitemid 351439202)
9. Durham WJ, Aracena-Parks P, Long C, Rossi AE, Goonasekera SA, Boncompagni S, Galvan DL, Gilman CP, Baker MR, Shirokova N, et al. (2008) RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 133:53-65.
10. 2+ in skeletal myotubes. J Biol Chem 285:13781-13787.
11. 2+ entry, release, and retrograde signaling to the DHPR. J Gen Physiol 135:619-628.
12. Feng W, Liu G, Allen PD, and Pessah IN (2000) Transmembrane redox sensor of ryanodine receptor complex. J Biol Chem 275:35902-35907.
13. Flucher BE and Franzini-Armstrong C (1996) Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle. Proc Natl Acad Sci USA 93:8101-8106. (Pubitemid 26277172)
14. Guo T, Cornea RL, Huke S, Camors E, Yang Y, Picht E, Fruen BR, and Bers DM (2010) Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks. Circ Res 106:1743-1752.
15. Hwang C, Lodish HF, and Sinskey AJ (1995) Measurement of glutathione redox state in cytosol and secretory pathway of cultured cells. Methods Enzymol 251:212-221.
16. Kimura T, Lueck JD, Harvey PJ, Pace SM, Ikemoto N, Casarotto MG, Dirksen RT, and Dulhunty AF (2009) Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling. Cell Calcium 45:264-274.
17. 2+ release in skinned skeletal muscle fibers. Am J Physiol Cell Physiol 281:C207-C214.
18. Laver DR, Baynes TM, and Dulhunty AF (1997a) Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J Membr Biol 156:213-229. (Pubitemid 27208424)
19. 2+ release channels in malignant hyperthermia. Biophys J 73:1913-1924.
20. Lehmann-Horn F, Jurkat-Rott K, Rüdel R, and Ulm Muscle Centre (2008) Diagnostics and therapy of muscle channelopathies - guidelines of the Ulm Muscle Centre. Acta Myol 27:98-113.
21. Mack MM, Molinski TF, Buck ED, and Pessah IN (1994) Novel modulators of skeletal muscle FKBP12/calcium channel complex from Ianthella basta: role of FKBP12 in channel gating. J Biol Chem 269:23236-23249.
22. Marengo JJ, Hidalgo C, and Bull R (1998) Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 74:1263-1277. (Pubitemid 28108536)
23. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, and Marks AR (2000) PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365-376.
24. 3H1 cells. Am J Physiol 272:C601-C614.
25. Protasi F (2002) Structural interaction between RYRs and DHPRs in calcium release units of cardiac and skeletal muscle cells. Front Biosci 7:d650-d658.
26. Reiken S, Lacampagne A, Zhou H, Kherani A, Lehnart SE, Ward C, Huang F, Gaburjakova M, Gaburjakova J, Rosemblit N, et al. (2003) PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol 160:919-928. (Pubitemid 36350846)
27. Robinson R, Carpenter D, Shaw MA, Halsall J, and Hopkins P (2006) Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 27:977-989. (Pubitemid 44454050)
28. Robinson RL, Anetseder MJ, Brancadoro V, van Broekhoven C, Carsana A, Censier K, Fortunato G, Girard T, Heytens L, Hopkins PM, et al. (2003) Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet 11:342-348. (Pubitemid 36553493)
29. Sheridan DC, Takekura H, Franzini-Armstrong C, Beam KG, Allen PD, and Perez CF (2006) Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc Natl Acad Sci USA 103:19760-19765. (Pubitemid 46037504)
30. 2+ release mediated by ryanodine receptors. Mol Pharmacol 69:532-538.
31. Takeshima H, Iino M, Takekura H, Nishi M, Kuno J, Minowa O, Takano H, and Noda T (1994) Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369:556-559. (Pubitemid 24192522)
32. 2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle. Biophys J 96:35-44.
33. Tung CC, Lobo PA, Kimlicka L, and Van Petegem F (2010) The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 468:585-588.
34. Voss AA, Allen PD, Pessah IN, and Perez CF (2008) Allosterically coupled calcium and magnesium binding sites are unmasked by ryanodine receptor chimeras. Biochem Biophys Res Commun 366:988-993.
35. Voss AA, Lango J, Ernst-Russell M, Morin D, and Pessah IN (2004) Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry. J Biol Chem 279:34514-34520. (Pubitemid 39318079)
36. Yang T, Allen PD, Pessah IN, and Lopez JR (2007a) Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem 282:37471-37478.
37. Yang T, Esteve E, Pessah IN, Molinski TF, Allen PD, and López JR (2007b) Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol 292:C1591-C1598. (Pubitemid 47080573)
38. Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, and Lopez JR (2006) Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology 105:1164-1175. (Pubitemid 44808580)
39. Zhou J, Allen PD, Pessah IN, and Naguib M (2010) Neuromuscular disorders and malignant hyperthermia, in Miller's Anesthesia (Miller RD ed) p 1171, Churchill Livingstone, Philadelphia.
40. 2+ sparks demonstrated in cultured mammalian muscle. Am J Physiol Cell Physiol 290:C539-C553.